A common drug taken by people suffering from diabetes may help prevent the further growth of cysts in polycystic kidney disease, a new study has found. The drug, pioglitazone, which is taken by diabetics for insulin resistance, was revealed to halt the growth of fluid-filled cysts in polycystic kidney disease (PKD), a common genetic disorder.
The study, by scientists at Indiana University-Purdue University Indianapolis and the Mayo Clinic, involved a rat model with the same genetic mutation as a form of human PKD, which was independently tested by both groups with pioglitazone. It was found that the drug appeared to slow down the growth of kidney and liver cysts by inhibiting a chloride channel in the cells of the organs.
The study, which was published in the journal PPAR Research, is part of current research into PKD, which currently has no cure and little in the way of viable and effective therapies, with the most usual treatment being a kidney transplant .
Bonnie Blazer-Yost, corresponding author on the study, commented "We thought that since this class of drugs inhibits the body's chloride channels, then it would be a good candidate to treat PKD, a disease in which excessive chloride and water are transported into the cysts of the kidneys and the liver causing them to expand."
She added "The finding that pioglitazone, which has already been approved by the Food and Drug Administration for diabetes, can halt cyst progression and may be an effective and well-tolerated treatment for this chronic disease, is exciting. Confirmation of these results in other animal models of PKD would be a useful next step."
Diabetes drug, pioglitazone, could help combat kidney disease
Mon, 15 Nov 2010
Your comments may be moderated. Please report any spam, illegal, offensive or libellous posts.
Also related to this storyDiabetes Products
Diabetes Food and Recipes
Healthcare Professionals and Diabetes
Glossary of Diabetes Terms - pioglitazone
The Diet Plate Clinically Proven to Control Diabetes
Blood Sugar Meter Giveaway
Diabetes and Alcohol
Guides for Diabetics in India
Obesity drug lorcaserin shown to be effective against diabetes
Benefits of diabetes related drug, statins, in doubt for the elderly
Diabetes drugs could help combat lung cancer
Diabetes drug teplizumab fails in tests
Date of switch from diabetes drug Avandia to alternative announced
New trial for diabetes drug dapagliflozin
Diabetes drug Avandia, rosiglitazone, under further attack from European regulators
Diabetes drug linagliptin shown to be safe in tests
New diabetes drug lixisenatide shows well in tests
Link found between diabetes drug Actos and bladder cancer
Trials of new diabetes drug suspended
Daily diabetes drug approved for NHS
Diabetes drug Avandia still being prescribed
Diabetes drug can reduce lung cancer for smokers
Competing diabetes drug to Avandia not safe either, new study reveals
Advinus complete first phase of trials for type 2 diabetes drug
Another diabetes drug under suspicion
Diabetes drug Avandia backed by health group
Is Avandia a risky drug
Anti-diabetes drug linked to heart problems
New diabetes drugs being developed
Diet and exercise better than drugs for reducing heart risks in diabetics
Diabetes drug to be withdrawn
Low doses of drug can help prevent diabetes
Diabetes drug Vitamin B12 deficiency